Urinary eicosanoid and tyrosine derivative concentrations in patients with vasculitides

Journal of Allergy and Clinical Immunology

Volumn 114, Issue 6, 2004, Pages 1353-1358

  Higashi, Noritaka ^a,b,c   Mita, Haruhisa ^a   Taniguchi, Masami ^a   Turikisawa, Naomi ^a   Higashi, Ai ^a,b   Ozawa, Yoshinori ^a   Tohma, Shigeto ^a   Arimura, Kimiyoshi ^b   Akiyama, Kazuo ^a  

^a SAGAMIHARA NATIONAL HOSPITAL   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c PO Box 287   (United States)

Author keywords

3 bromotyrosine; 3 chlorotyrosine; Churg Strauss syndrome; leukotriene E 4; vasculitides

Indexed keywords

11 EPIPROSTAGLANDIN F2 ALPHA; 3 BROMOTYROSINE; 3 CHLOROTYROSINE; AUTACOID; BIOLOGICAL MARKER; EOSINOPHIL PEROXIDASE; EOSINOPHIL PROTEIN X; LEUKOTRIENE E4; TYROSINE DERIVATIVE; UNCLASSIFIED DRUG;

ACUTE DISEASE; ADULT; AGED; ALLERGIC VASCULITIS; ARTICLE; CHURG STRAUSS SYNDROME; CONTROLLED STUDY; DISEASE EXACERBATION; ENZYME IMMUNOASSAY; EOSINOPHIL; FEMALE; GAS CHROMATOGRAPHY; HUMAN; MALE; MASS SPECTROMETRY; OXIDATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REMISSION; RHEUMATOID ARTHRITIS; SMALL VESSEL VASCULITIS; TISSUE INJURY; URINE LEVEL; VASCULITIDIS;

ADULT; AGED; CHURG-STRAUSS SYNDROME; EICOSANOIDS; EOSINOPHIL-DERIVED NEUROTOXIN; FEMALE; HUMANS; LEUKOTRIENE E4; MALE; MIDDLE AGED; TYROSINE; VASCULITIS;

EID: 9644290855     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2004.09.027     Document Type: Article

References (51)

1. E.C. Jong, W.R. Henderson, and S.J. Klebanoff Bactericidal activity of eosinophil peroxidase J Immunol 124 1980 1378 1382
2. R.M. Ten, L.R. Pease, D.J. McKean, M.P. Bell, and G.J. Gleich Molecular cloning of the human eosinophil peroxidase: evidence for the existence of a peroxidase multigene family J Exp Med 169 1989 1757 1769
3. K. Sakamaki, M. Tomonaga, K. Tsukui, and S. Nagata Molecular cloning and characterization of a chromosomal gene for human eosinophil peroxidase J Biol Chem 264 1989 16828 16836
4. M.G. Carlson, C.G. Peterson, and P. Venge Human eosinophil peroxidase: purification and characterization J Immunol 134 1985 1875 1879
5. S.J. Klebanoff, R.M. Locksley, E.C. Jong, and H. Rosen Oxidative response of phagocytes to parasite invasion Ciba Found Symp 99 1983 92 112
6. S.J. Weiss, S.T. Test, C.M. Eckmann, D. Roos, and S. Regiani Brominating oxidants generated by human eosinophils Science 234 1986 200 203
7. E.L. Thomas, P.M. Bozeman, M.M. Jefferson, and C.C. King Oxidation of bromide by the human leukocyte enzymes myeloperoxidase and eosinophil peroxidase: formation of bromamines J Biol Chem 270 1995 2906 2913
8. W. Wu, Y. Chen, A. d'Avignon, and S.L. Hazen 3-Bromotyrosine and 3,5-dibromotyrosine are major products of protein oxidation by eosinophil peroxidase: potential markers for eosinophil-dependent tissue injury in vivo Biochemistry 38 1999 3538 3548
9. E.A. Podrez, H.M. Abu-Sound, and S.L. Hazen Myeloperoxidase-generated oxidants and atherosclerosis Free Radic Biol Med 28 2000 1717 1725
10. S.J. Weiss, R. Klein, A. Slivka, and M. Wei Chlorination of taurine by human neutrophils: evidence for hypochlorous acid generation J Clin Invest 70 1982 598 607
11. C.S. Foote, T.E. Goyne, and R.I. Lehrer Assessment of chlorination by human neutrophils Nature 301 1983 715 716
12. S.L. Hazen, F.F. Hsu, D.M. Mueller, J.R. Crowley, and J.W. Heinecke Human neutrophils employ chloride gas as an oxidant during phagocytosis J Clin Invest 98 1996 1283 1289
13. W. Wu, M.K. Samoszuk, S.A. Comhair, M.J. Thomassen, C.F. Farver, and R.A. Dweik Eosinophils generate brominating oxidants in allergen-induced asthma J Clin Invest 105 2000 1455 1463
14. J.G. Lanham, K.B. Elkon, C.D. Pusey, and G.R. Hughes Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome Medicine 63 1984 65 81
15. L. Guillevin, P. Cohen, M. Gayraud, F. Lhote, B. Jarrousse, and P. Casassus Churg-Strauss syndrome: clinical study and long-term follow-up of 96 patients Medicine 78 1999 26 37
16. J.C. Jennette, A.S. Wilkman, and R.J. Falk Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis Am J Pathol 35 1989 921 930
17. W.H. Schmitt, E. Csernok, S. Kobayashi, A. Klinkenborg, E. Reinhold-Keller, and W.L. Gross Churg-Strauss syndrome: serum markers of lymphocyte activation and endothelial damage Arthritis Rheum 41 1998 445 452
18. S.L. Hazen, and J.W. Heinecke 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima J Clin Invest 99 1997 2075 2081
19. F.J. van der Woude, N. Rasmussen, S. Lobatto, A. Wiik, H. Permin, and L.A. van Es Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis Lancet 1 1985 425 429
20. R.J. Falk, and J.C. Jenette Anti-neutrophil cytoplasmic antibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotising and crescenteric glomerulonephritis N Engl J Med 318 1988 1651 1657
21. J. Savige, D. Gillis, E. Benson, D. Davies, V. Esnault, and R.J. Falk International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA) Am J Clin Pathol 111 1999 507 513
22. J.S. Sundy, and B.F. Haynes Pathogenic mechanisms of vessel damage in vasculitis syndromes Rheum Dis Clin North Am 21 1995 861 881
23. E. Mayatepek, and W.D. Lehmann Increased generation of cysteinyl leukotrienes in Kawasaki disease Arch Dis Child 72 1995 526 527
24. P.F. Weller, M. Plaut, V. Taggart, and A. Trontell The relationship of asthma therapy and Churg-Strauss syndrome: NIH workshop summary report J Allergy Clin Immunol 108 2001 175 183
25. A.T. Masi, G.G. Hunder, J.T. Lie, B.A. Michel, D.A. Bloch, and W.P. Arend The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis) Arthritis Rheum 33 1990 1094 1100
26. J.C. Jennette, R.J. Falk, K. Andrassy, P.A. Bacon, J. Churg, and W.L. Gross Nomenclature of systemic vasculitis: proposal of an International Consensus Conference Arthritis Rheum 37 1994 187 192
27. N. Tsurikisawa, M. Taniguchi, H. Saito, H. Himeno, A. Ishibashi, and S. Suzuki Treatment of Churg-Strauss syndrome with high-dose intravenous immunoglobulin Ann Allergy Asthma Immunol 92 2004 80 87
28. R.Y. Leavitt, A.S. Fauci, D.A. Bloch, B.A. Michel, G.G. Hunder, and W.P. Arend The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis Arthritis Rheum 33 1990 1101 1107
29. G.G. Hunder, D.A. Bloch, B.A. Michel, M.B. Stevens, W.P. Arend, and L.H. Calabrese The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis Arthritis Rheum 33 1990 1122 1128
30. F.C. Arnett, S.M. Edworthy, D.A. Bloch, D.J. McShane, J.F. Fries, and N.S. Cooper The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 31 1988 315 324
31. N. Higashi, M. Taniguchi, H. Mita, M. Osame, and K. Akiyama A comparative study of eicosanoid concentration in sputum and urine in the patients with aspirin-intolerant asthma Clin Exp Allergy 32 2002 1484 1490
32. H. Mita, N. Higashi, M. Taniguchi, A. Higashi, Y. Kawagishi, and K. Akiyama Urinary 3-bromotyrosine and 3-chlorotyrosine concentrations in asthmatic patients: lack of increase in 3-bromotyrosine concentration in urine and plasma proteins in aspirin-induced asthma after aspirin challenge Clin Exp Allergy 34 2004 931 938
33. M.T. Frost, B. Halliwall, and K.P. Moore Analysis of free and protein-bound nitrotyrosine in human plasma by a gas chromatography/mass spectrometry method that avoids nitration artifacts Biochem J 345 2000 453 458
34. J.P. Gaut, J. Byun, H.D. Tran, and J.W. Heinecke Artifact-free quantification of free 3-chlorotyrosine, bromotyrosine, and 3-nitrotyrosine in human plasma by electron capture-negative chemical ionization gas chromatography mass spectrometry and liquid chromatography-electrospray ionization tandem mass spectrometry Anal Biochem 300 2002 252 259
35. M. Kumlin Measurements of leukotrienes in the urine: strategies and applications Allergy 52 1997 124 135
36. 1 receptor Eur J Biochem 268 2001 2578 2586
37. A.P. Sampson Leukotrienes in cardiovascular disease Clin Exp Allergy Rev 1 2001 170 174
38. D.A. Brezinski, R.W. Nesto, and C.N. Serhan Angioplasty triggers intracoronary leukotrienes and lipoxin A4: impact of aspirin therapy Circulation 86 1992 56 63
39. A. Szczeklik, E. Nizankowska, L. Mastalerz, and G. Bochenek Myocardial ischemia possibly mediated by cysteinyl leukotrienes J Allergy Clin Immunol 109 2002 572 573
40. N. Higashi, M. Taniguchi, H. Mita, Y. Kawagishi, T. Ishii, and A. Higashi Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): involvement of chronic hyperplastic rhinosinusitis with nasal polyposis J Allergy Clin Immunol 113 2004 277 283
41. A. Szczeklik, and D.D. Stevenson Aspirin-induced asthma: advances in pathogenesis, diagnosis and management J Allergy Clin Immunol 111 2003 913 921
42. L. Mastalerz, M. Setkowicz, M. Sanak, and A. Szczeklik Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma J Allergy Clin Immunol 113 2004 771 775
43. L.A. Laitinen, A. Laitinen, T. Haahtela, V. Vilkka, B.W. Spur, and T.H. Lee Leukotriene E4 and granulocytic infiltration into asthmatic airways Lancet 341 1993 989 990
44. J.C. MacPherson, S.A. Comhair, S.C. Erzurum, D.F. Klein, M.F. Lipscomb, and M.S. Kavuru Eosinophils are a major source of nitric oxide-derived oxidants in severe asthma: characterization of pathways available to eosinophils for generating reactive nitrogen species J Immunol 166 2001 5763 5772
45. R.E. Aldridge, T. Chan, C.J. van Dalen, R. Senthilmohan, M. Winn, and P. Venge Eosinophil peroxidase produces hypobromous acid in the airways of stable asthmatics Free Radic Biol Med 33 2002 847 856
46. S.T. Holgate The epidemic of allergy and asthma Nature 402 1999 B2 B4
47. P.F. Weller Eosinophils: structure and functions Curr Opin Immunol 6 1994 85 90
48. E. Sato, S.L. Camhi, S. Koyama, and R.A. Robbins Methotrexate stimulates lung fibroblasts and epithelial cells to release eosinophil chemotactic activity J Rheumatol 28 2001 502 508
49. J.A. Cooper Jr., D.A. White, and R.A. Matthay Drug-induced pulmonary disease, part 1: cytotoxic drugs Am Rev Respir Dis 133 1986 321 340
50. C. Evereklioglu, E. Özbek, M. çekmen, N. Mehmet, N. Duygulu, and A. Ozkiris Urinary nitric oxide levels are increased and correlated with plasma concentrations in patients with Behçet's disease: is it a new urinary activity marker? Nephrology (Carlton) 8 2003 231 238
51. A.R. Mani, A.S. Pannala, N.N. Orie, R. Ollosson, D. Harry, and C.A. Rice-Evans Nitration of endogenous para-hydroxyphenylacetic acid and the metabolism of nitrotyrosine Biochem J 374 2003 521 527